Levofloxacino Aurovitas

Levofloxacin, the active ingredient in Levofloxacino Aurovitas, is a fluoroquinolone antibiotic presented as an oral dosage form for oral use. It is prescribed to treat a variety of bacterial infections—including respiratory, urinary, and skin infections—in both adult and pediatric patients when appropriate.

GNH USA supplies Levofloxacino Aurovitas as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, adhering to EU quality standards and providing reliable global distribution with dedicated regulatory support. The company ensures batch traceability, temperature‑controlled logistics where required, and compliance with import regulations for each market.

Levofloxacin is a broad‑spectrum fluoroquinolone used to treat infections caused by susceptible bacteria in several organ systems.

- Community‑Acquired Pneumonia: achieves clinical cure and bacterial eradication in typical adult cases. - Acute Bacterial Sinusitis: reduces symptoms and clears the infecting organisms. - Uncomplicated Urinary Tract Infection: provides rapid bacterial clearance and symptom relief. - Skin and Soft Tissue Infections: effective against common Gram‑positive and Gram‑negative pathogens. - Acute Exacerbation of Chronic Bronchitis: shortens illness duration and improves lung function.

Levofloxacin may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea - Diarrhea - Headache - Dizziness - Abdominal pain

Serious or Rare Side Effects: - Tendon rupture or inflammation - QT interval prolongation leading to arrhythmia - Severe allergic reactions such as anaphylaxis - Clostridioides difficile‑associated colitis - Peripheral neuropathy or Stevens‑Johnson syndrome

Before prescribing levofloxacin, clinicians should consider several precautionary measures to minimize risks.

- Renal impairment: dose adjustment may be required based on creatinine clearance. - History of tendon disorders: avoid use or monitor closely for tendon pain or swelling. - Cardiac arrhythmias: assess QT interval and avoid in patients with known prolongation. - Concomitant NSAIDs: increased risk of central nervous system stimulation. - Pregnancy and lactation: use only if potential benefits outweigh potential risks. - Store at ambient temperature: keep in original container, protect from moisture and light.

Levofloxacin can interact with other medicines, altering its effectiveness or increasing toxicity.

Major Interactions (Avoid): - Antacids containing aluminum or magnesium: reduce levofloxacin absorption. - Warfarin: may enhance anticoagulant effect and increase bleeding risk. - Theophylline: levofloxacin can raise plasma theophylline levels, causing toxicity. - Cyclosporine: increased risk of nephrotoxicity when combined. - Other fluoroquinolones (e.g., ciprofloxacin): additive toxicity; concurrent use should be avoided.

Moderate Interactions (Monitor Closely): - NSAIDs: may increase risk of central nervous system stimulation. - Corticosteroids: combined use raises risk of tendon rupture. - Insulin or sulfonylureas: potential for hypoglycemia. - Rifampin: may lower levofloxacin concentrations, reducing efficacy. - Antidiabetic agents: monitor blood glucose for possible alterations.